Ramsay Health Care shares rebound 15% in June: Can they keep going?

Group of doctors celebrate by pumping fists in the air

Ramsay Health Care Ltd (ASX: RHC) shares have climbed higher into the green on Thursday morning.

At the time of writing, the ASX healthcare shares are up around 1% and changing hands at $41.62 a piece.

Today’s increase comes off the back of a 3.5% price hike yesterday.

The latest share price increase means Ramsay Health Care shares have now recovered around 15% from a dip in early June, and are around 20% higher for the year to date. Over the past year, the shares have risen 17%.

What happened to Ramsay Health Care shares?

Ramsay Health Care is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

The company faced several headwinds in 2025, including depressed earnings, market volatility, and ongoing cost pressures.

The ASX healthcare sector overall was under immense pressure throughout late 2025 and into early 2026 as macroeconomic pressures, rising inflation, higher cost of living, and regulatory uncertainty have driven a sector-wide share price downturn.

Why are the ASX healthcare shares now rebounding?

There hasn’t been any price sensitive news out of Ramsay Health Care shares to explain the share price turnaround in June.

It’s likely the result of an overall ASX healthcare sector recovery as investors rotated back into heavily-discounted healthcare names, and improved sentiment following the company’s latest earnings results.

The recovery has also been supported by a turnaround in the company’s finances. Ramsay Health Care posted its first-half FY26 results in February, where it confirmed underlying EBIT had grown 7.3%, underlying NPAT was up 8.1%, and its Australian hospital revenue was 8.2% higher. The company’s shares spiked over 10% on the day of the result.

The stronger half-year result seems to have helped investor sentiment shift from concerns about cost pressures and volatility towards a recovery story.

To me it looks like investors are still snapping up the shares while they’re trading for cheap.

Can Ramsay Health Care shares keep climbing higher? Here’s what the experts think

Analysts and brokers are divided about the outlook for Ramsay Health Care shares over the next 12 months.

Market Index data shows brokers are split between a buy and a sell rating. The average $40.60 target price, however, implies a potential 3% downside at the time of writing.

On TradingView data, sentiment is also split. Out of 12 analysts, seven have a hold rating on the healthcare stock. Another four rate the shares as a buy or strong buy and one has a strong sell stance.

The average $41.30 target price implies a downside of around 1% at the time of writing. But some expect the shares to jump 13% higher to $47.17, and others tip the stock to crash 20% back down to $32.90 a piece.

The post Ramsay Health Care shares rebound 15% in June: Can they keep going? appeared first on The Motley Fool Australia.

Should you invest $1,000 in Ramsay Health Care right now?

Before you buy Ramsay Health Care shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Ramsay Health Care wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 16 June 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.